247 related articles for article (PubMed ID: 19491392)
1. Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production.
Fang C; Zhang X; Miwa T; Song WC
Blood; 2009 Jul; 114(5):1005-15. PubMed ID: 19491392
[TBL] [Abstract][Full Text] [Related]
2. Complement activation product C5a is a selective suppressor of TLR4-induced, but not TLR3-induced, production of IL-27(p28) from macrophages.
Bosmann M; Haggadone MD; Hemmila MR; Zetoune FS; Sarma JV; Ward PA
J Immunol; 2012 May; 188(10):5086-93. PubMed ID: 22491257
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease.
Reynolds JM; Pappu BP; Peng J; Martinez GJ; Zhang Y; Chung Y; Ma L; Yang XO; Nurieva RI; Tian Q; Dong C
Immunity; 2010 May; 32(5):692-702. PubMed ID: 20434372
[TBL] [Abstract][Full Text] [Related]
4. Complement drives Th17 cell differentiation and triggers autoimmune arthritis.
Hashimoto M; Hirota K; Yoshitomi H; Maeda S; Teradaira S; Akizuki S; Prieto-Martin P; Nomura T; Sakaguchi N; Köhl J; Heyman B; Takahashi M; Fujita T; Mimori T; Sakaguchi S
J Exp Med; 2010 Jun; 207(6):1135-43. PubMed ID: 20457757
[TBL] [Abstract][Full Text] [Related]
5. TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2.
Raby AC; Holst B; Davies J; Colmont C; Laumonnier Y; Coles B; Shah S; Hall J; Topley N; Köhl J; Morgan BP; Labéta MO
Eur J Immunol; 2011 Sep; 41(9):2741-52. PubMed ID: 21630250
[TBL] [Abstract][Full Text] [Related]
6. IL-9 as a mediator of Th17-driven inflammatory disease.
Nowak EC; Weaver CT; Turner H; Begum-Haque S; Becher B; Schreiner B; Coyle AJ; Kasper LH; Noelle RJ
J Exp Med; 2009 Aug; 206(8):1653-60. PubMed ID: 19596803
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo.
Zhang X; Kimura Y; Fang C; Zhou L; Sfyroera G; Lambris JD; Wetsel RA; Miwa T; Song WC
Blood; 2007 Jul; 110(1):228-36. PubMed ID: 17363730
[TBL] [Abstract][Full Text] [Related]
8. Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
Derkow K; Krüger C; Dembny P; Lehnardt S
PLoS One; 2015; 10(8):e0135898. PubMed ID: 26288016
[TBL] [Abstract][Full Text] [Related]
9. MyD88-dependent production of IL-17F is modulated by the anaphylatoxin C5a via the Akt signaling pathway.
Bosmann M; Patel VR; Russkamp NF; Pache F; Zetoune FS; Sarma JV; Ward PA
FASEB J; 2011 Dec; 25(12):4222-32. PubMed ID: 21859896
[TBL] [Abstract][Full Text] [Related]
10. C5a negatively regulates toll-like receptor 4-induced immune responses.
Hawlisch H; Belkaid Y; Baelder R; Hildeman D; Gerard C; Köhl J
Immunity; 2005 Apr; 22(4):415-26. PubMed ID: 15845447
[TBL] [Abstract][Full Text] [Related]
11. Augmenting DAF levels in vivo ameliorates experimental autoimmune encephalomyelitis.
Li Q; Huang D; Nacion K; Bu H; Lin F
Mol Immunol; 2009 Sep; 46(15):2885-91. PubMed ID: 19660813
[TBL] [Abstract][Full Text] [Related]
12. Toll-Like Receptor 4 Promotes Th17 Lymphocyte Infiltration Via CCL25/CCR9 in Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Zhang Y; Han J; Wu M; Xu L; Wang Y; Yuan W; Hua F; Fan H; Dong F; Qu X; Yao R
J Neuroimmune Pharmacol; 2019 Sep; 14(3):493-502. PubMed ID: 31065973
[TBL] [Abstract][Full Text] [Related]
13. A Novel Role for C5a in B-1 Cell Homeostasis.
Bröker K; Figge J; Magnusen AF; Manz RA; Köhl J; Karsten CM
Front Immunol; 2018; 9():258. PubMed ID: 29520270
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation.
Reynolds JM; Martinez GJ; Chung Y; Dong C
Proc Natl Acad Sci U S A; 2012 Aug; 109(32):13064-9. PubMed ID: 22826216
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptors in multiple sclerosis mouse experimental models.
Marta M
Ann N Y Acad Sci; 2009 Sep; 1173():458-62. PubMed ID: 19758186
[TBL] [Abstract][Full Text] [Related]
16. Evidence for anti-inflammatory effects of C5a on the innate IL-17A/IL-23 axis.
Bosmann M; Sarma JV; Atefi G; Zetoune FS; Ward PA
FASEB J; 2012 Apr; 26(4):1640-51. PubMed ID: 22202675
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory responses induced by lipopolysaccharide are amplified in primary human monocytes but suppressed in macrophages by complement protein C5a.
Seow V; Lim J; Iyer A; Suen JY; Ariffin JK; Hohenhaus DM; Sweet MJ; Fairlie DP
J Immunol; 2013 Oct; 191(8):4308-16. PubMed ID: 24043889
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis.
Reiman R; Gerard C; Campbell IL; Barnum SR
Eur J Immunol; 2002 Apr; 32(4):1157-63. PubMed ID: 11932923
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production.
Liu J; Lin F; Strainic MG; An F; Miller RH; Altuntas CZ; Heeger PS; Tuohy VK; Medof ME
J Immunol; 2008 May; 180(9):5882-9. PubMed ID: 18424707
[TBL] [Abstract][Full Text] [Related]
20. Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses.
Rudilla F; Fayolle C; Casares N; Durantez M; Arribillaga L; Lozano T; Villanueva L; Pio R; Sarobe P; Leclerc C; Prieto J; Lasarte JJ
Vaccine; 2012 Apr; 30(18):2848-58. PubMed ID: 22387222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
